MKM Pharma Consulting ApS
CVR 44951959 · Private limited company (ApS) · Active · Medium risk
MKM Pharma Consulting ApS is a Private limited company (ApS), founded on , based in Kastrup. The company is registered in the industry andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. Our model estimates a bankruptcy risk of 2.3% over the next 12 months, which is 1.6 times the average for Danish companies. 1 annual report has been published. The latest annual report (31 Dec 2025) shows equity of DKK 175k and a net result of DKK 135k. CEO: Maiken Kaas Mortensen.
Bankruptcy risk for MKM Pharma Consulting ApS
1.6 × the average (1.41%) · higher risk than 84% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 44951959
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (2 years)
- Address
- Viskumvej 18
2770 Kastrup - Municipality
- Tårnby
- Industry
- Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. (749990)
Bankruptcies in the industry: Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. - Share capital
- DKK 40k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 1 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 32.0% |
| Current ratio | 147% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 0 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 |
|---|---|
| Gross profit | DKK 2.5m |
| Net profit | DKK 135k |
| Equity | DKK 175k |
| Total assets | DKK 546k |
| Cash | DKK 300k |
| Short-term debt | DKK 371k |
| Tax owed | DKK 38k |
| Avg. employees | 1 |
Latest annual report: Reporting class B · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 3 Jul 2024 – 31 Dec 2025 | 158 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Maiken Kaas Mortensen | Current | |
| Owner (100%) | Maiken Kaas Mortensen | Current | |
| Founder | Maiken Kaas Mortensen | Current |
Address history (0 moves)
| Viskumvej 18, 2770 Kastrup |
Similar companies in Tårnby
- Sigma Connectivity ApS Kastrup
- Verwaltung ApS Kastrup
- Vento Maritime ApS Kastrup
- Silvertip Agency ApS Kastrup
- Clausens Consulting ApS Kastrup
- Personalized Weight Management Research Consortium ApS Kastrup
- PROINSIDE IVS Kastrup
- ACT.Global Healthcare ApS Kastrup
- ACT.Global Sport ApS Kastrup
- Tankmar consulT IVS Kastrup
- ACT.Global Marine ApS Kastrup
- J P NORDIC ApS Kastrup
Questions and answers about MKM Pharma Consulting ApS
Has MKM Pharma Consulting ApS gone bankrupt?
No, MKM Pharma Consulting ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of MKM Pharma Consulting ApS?
Our model estimates a bankruptcy risk of 2.3% over the next 12 months (medium risk), which is 1.6 times the average for Danish companies.
Who is the CEO of MKM Pharma Consulting ApS?
Maiken Kaas Mortensen is the CEO of MKM Pharma Consulting ApS.
When was MKM Pharma Consulting ApS founded?
MKM Pharma Consulting ApS was founded on 3 July 2024.
What is the equity of MKM Pharma Consulting ApS?
Equity was DKK 175k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.